综述:粪便钙卫蛋白与溃疡性结肠炎的组织学缓解
该系统综述检索PubMed/MEDLINE、EMBASE和Web of Science至2019年9月,纳入12项研究共1168例确诊溃疡性结肠炎患者,评估粪便钙卫蛋白水平与组织学活动的相关性。所有纳入研究均显示粪便钙卫蛋白水平与组织学之间存在明确相关性,但用于区分组织学缓解与活动的截断值在研究中从40.5至250 μg/g不等。作者认为粪便钙卫蛋白可预测组织学缓解,但截断值受检测试剂和组织学缓解定义影响,尚需采用经验证组织学指标的大型前瞻性研究确定全球公认的截断值。
要点
- 粪便钙卫蛋白与溃疡性结肠炎组织学活动性均呈明确相关
- 各研究区分组织学缓解的截断值不一,范围40.5–250 μg/g
- 截断值差异与检测试剂及组织学缓解定义不同有关
核心结论
- 粪便钙卫蛋白可用于预测溃疡性结肠炎患者的组织学缓解,但截断水平因研究所用检测方法和组织学缓解定义而异。
- 需采用经验证组织学指标的大型前瞻性研究来确定全球公认的粪便钙卫蛋白截断水平,以区分组织学缓解与组织学活动性疾病。
研究设计与样本
- 系统综述,检索PubMed/MEDLINE、EMBASE和Web of Science至2019年9月,纳入确诊溃疡性结肠炎且报告粪便钙卫蛋白水平与组织学分析相关性的研究。
- 最终纳入12项研究,共1168例患者。
主要发现
- 所有纳入研究均显示粪便钙卫蛋白水平与组织学之间存在明确相关性。
- 组织学缓解在5篇文章中按未经验证的评分定义,在7篇文章中按部分经验证的评分定义。
- 12项研究中有6项(50%)使用同一试剂盒测定粪便钙卫蛋白,其余6项各自采用不同试剂盒。
- 共识别出11个不同的粪便钙卫蛋白截断值用于区分组织学缓解与组织学活动,范围为40.5至250 μg/g。
关键数值与推荐
- 组织学缓解定义:5篇文章采用未经验证评分,7篇文章采用部分经验证评分。
- 粪便钙卫蛋白检测:6/12项研究(50%)使用同一试剂盒,其余6项研究使用各自不同的试剂盒。
- 区分组织学缓解与组织学活动的粪便钙卫蛋白截断值共11个,范围为40.5至250 μg/g。
临床怎么用
- 粪便钙卫蛋白可作为溃疡性结肠炎组织学缓解的非侵入性预测指标,减少反复内镜和活检的需求。
- 解读粪便钙卫蛋白截断值时需考虑所用检测试剂及所采用的组织学缓解定义,不宜直接套用单一阈值。
局限性
- 各研究组织学缓解定义不统一,多数为未经验证或仅部分经验证的评分。
- 粪便钙卫蛋白检测试剂盒不统一,仅半数研究使用同一试剂盒。
- 截断值研究间差异大(40.5至250 μg/g),尚无全球公认的截断水平。
- 需要更大规模、采用经验证组织学指标的前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Histologic healing is emerging as a new therapeutic goal in both routine practice and clinical trials in ulcerative colitis (UC). However, it requires repeated endoscopies and biopsies. Faecal calprotectin is a non-invasive marker of mucosal healing (endoscopic and histologic healing). AIM: To conduct a systematic review to clarify the correlation between faecal calprotectin levels and histologic activity in UC patients. METHODS: We searched PubMed/MEDLINE, EMBASE and Web of Science through September 2019 to identify studies in patients with confirmed diagnosis of UC, reporting the correlation between faecal calprotectin levels and histologic analysis. RESULTS: Twelve studies enrolling 1168 patients were included in the final review. Histologic remission was defined according to nonvalidated scores in five articles and using partially validated scores in seven articles. Faecal calprotectin values were measured in 6 of 12 studies (50%) with the same kit, while the remaining six studies adopted individually different kits. A clear correlation between faecal calprotectin levels and histology was showed in all included studies. Eleven different faecal calprotectin cut-off points were identified to distinguish histological remission from histological activity, ranging from 40.5 to 250 μg/g. CONCLUSIONS: Faecal calprotectin can be used to predict histologic remission in patients with UC, but the cut-off level varies across studies, according to the test used to measure this biomarker and according to the definition of histologic remission. Larger prospective studies using validated histologic indexes are needed to identify a globally accepted faecal calprotectin cut-off level to discriminate between histologic remission and histologically active disease.
引用
- D'Amico F, Bonovas S, Danese S, et al. Review article: faecal calprotectin and histologic remission in ulcerative colitis. Aliment Pharmacol Ther. 2020. PMID: 32048751. doi:10.1111/apt.15662
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。